Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative structure-pharmacokinetic relationship modelling.

M O Fouchécourt1, M Béliveau, K Krishnan

  • 1De'partement de santé environnementale et santé au travail, Faculté de médecine, Université de Montréal, PQ, Canada.

The Science of the Total Environment
|July 17, 2001
PubMed
Summary

Quantitative structure-pharmacokinetic relationship (QSPkR) models predict chemical behavior. Integrating quantitative structure-property relationships (QSPR) with physiologically-based pharmacokinetic (PBPK) models enhances predictions across different scenarios.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On-site plant-wax biomarker analysis for assessing soil-organic-microbial degradation in archaeological contexts: A case study from Southern India.

iScience·2025
Same author

Seasonally resolved stratigraphy at Jwalapuram India shows regional surface warming after the Toba volcanic super-eruption.

PNAS nexus·2025
Same author

Determination of optimum levels of binding antibody units (BAU) of new quantitative chemiluminescent immuno-assay (CLIA) in COVID-19 vaccinated volunteer blood donors.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2024
Same author

Derivation of whole blood biomonitoring equivalents for titanium for the interpretation of biomonitoring data.

Regulatory toxicology and pharmacology : RTP·2020
Same author

Derivation of whole blood biomonitoring equivalents for lithium for the interpretation of biomonitoring data.

Regulatory toxicology and pharmacology : RTP·2020
Same author

Toxicity testing in the 21st century: progress in the past decade and future perspectives.

Archives of toxicology·2019

Area of Science:

  • Pharmacokinetics and Toxicological Modeling
  • Computational Chemistry and Cheminformatics

Background:

  • Traditional quantitative structure-pharmacokinetic relationship (QSPkR) models rely on experimental data and have limited applicability.
  • Physiologically-based pharmacokinetic (PBPK) models offer broader extrapolation capabilities but require accurate parameterization.
  • Existing QSPkR methods are often constrained by specific experimental conditions and exposure scenarios.

Purpose of the Study:

  • To review current methods in quantitative structure-pharmacokinetic relationship (QSPkR) modeling.
  • To explore the integration of quantitative structure-property relationships (QSPR) with physiologically-based pharmacokinetic (PBPK) models.
  • To discuss advancements in structure-based pharmacokinetic modeling for toxicological risk assessment.

Main Methods:

Related Experiment Videos

  • Collecting pharmacokinetic data and fitting parameters (e.g., elimination half-life, volume of distribution).
  • Utilizing Free-Wilson models to associate chemical structures with pharmacokinetic parameters.
  • Developing QSPR models for PBPK parameters like partition coefficients and metabolic rates.

Main Results:

  • QSPkR models are limited to the conditions under which data were collected.
  • QSPR models for partition coefficients (blood:air, tissue:blood) are feasible, aiding PBPK model parameterization.
  • PBPK models can adequately simulate pharmacokinetics of inhaled volatile organic chemicals using estimated partition coefficients and hepatic extraction ratio limits.

Conclusions:

  • Mechanistic QSPRs for hepatic metabolism parameters are needed for comprehensive PBPK model development.
  • Integrated QSPR-PBPK modeling shows promise for predicting bioaccumulation and blood concentration profiles.
  • Advancements in structure-based pharmacokinetic modeling will improve chemical safety assessments and drug development.